2361 — Sinohealth Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$2.43bn
- HK$1.93bn
- CNY396.19m
- 84
- 32
- 87
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 67.1 | 76.1 | 95.5 | 54.5 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -12.1 | -14.3 | -9.05 | -21.1 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.05 | -8.04 | -33.8 | -9.47 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 57.8 | 61.6 | 60 | 32.6 | — |
Capital Expenditures | -4.43 | -1.18 | -3.05 | -4.18 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -176 | -165 | -6.42 | 119 | — |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -181 | -167 | -9.47 | 114 | — |
Financing Cash Flow Items | -0.529 | 3.65 | -312 | -4.83 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4.05 | 0.103 | -132 | 219 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -127 | -105 | -81.8 | 375 | — |